Measurement of tumor "size" in recurrent malignant glioma: 1D, 2D, or 3D?

Abstract

Indirect unidimensional and bidimensional measurement techniques do not have a significant association with overall survival or adequately assess tumor size in recurrent malignant glioma. These findings have serious implications about the validity of using current response assessment protocols in therapy trials for recurrent malignant glioma.